Financials

Figures converted from INR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, multiples, and share counts are unitless and unchanged.

Financials — what the numbers say, with receipts

eClerx is a small-cap Indian knowledge-process outsourcer with the financial profile of a high-quality compounder: low-double-digit dollar revenue growth, structural EBITDA margins in the mid-to-high 20s, mid-20s ROE, no funded debt, and an FY26 free cash flow margin of roughly 18% on revenue. Management closed the year reporting USD 469 million in operating revenue (up 17.9%), EBITDA up 29% to $128 million and net profit up 30% to $79 million [1]. The investment debate is not whether the financials are good — they are — but whether the market is paying a deserved premium for a small, BFSI-concentrated franchise that now has to prove its analytics-and-AI pivot before peers catch up.

How to read these statements

eClerx is a "people-on-a-bench" business: ~75% of FY26 operating expenses were employee benefits and sub-contractor costs, the rest being rent (capitalised under Ind-AS 116), travel, and tech. The way to read the income statement is therefore as a spread — billable revenue per head minus loaded labour cost, with leverage on utilisation. Three terms recur and matter:

• Operating revenue (OPG): revenue from operations, the top line investors track. Total revenue also includes Other Income (treasury yield, FX gains), which can be 2–3% of the top line and is what flips into "EBITDA including other income."
• Operating EBITDA: EBITDA excluding other income — management started disclosing this from FY26 because it's "a more meaningful number to look at" [2]. The 24–28% band guidance refers to this number.
• ACV (Annual Contract Value): the run-rate of new deals signed in a quarter — a leading indicator for revenue 2–3 quarters out.

The company sells primarily into BFSI (40.8% of FY26 revenue), Communications/Media/Tech (25.7%), Hi-Tech & Manufacturing (16.5%), Fashion & Luxury (8.6%), and an Emerging segment (8.4%) [3]. Knowing that mix is a prerequisite for reading the margin trend.

Eight-year statements — at a glance

The single most important table on the page: revenue, profitability, cash generation, balance sheet, and returns by fiscal year (Indian FY ends March 31). FY25 figures match the audited Annual Report; FY26 figures match the Price Waterhouse-audited Q4/full-year results filed with BSE [4].

Two things this table does that a single annual report cannot: it lets you see the structural rerating after the new leadership transition in FY24-25 (margins compressed but cash conversion surged), and it shows that FY26 EPS halved not because earnings collapsed but because of a 1:1 bonus issue effective March 2026 — paid-up equity capital doubled from $5.5M to $10.2M as the share count went from 47.0M to 92.0M shares [4]. Read the FY26 EPS as the new share-count denominator, not as a decline.

Growth — durable, with a meaningful FY26 step-up

Revenue compounded at 12.1% in USD terms over seven years, with two distinct phases: a flat FY19–FY21 stretch (the COVID year) and a high-teens CAGR run after FY21. The FY22 jump (+38%) reflects the Personiv acquisition annualising and BFSI capacity catching demand; the FY26 +17.9% in USD is mostly organic and reflects the analytics & automation pivot landing — that book is now a USD 90 million practice [1]. The 4-year revenue CAGR from FY22 to FY26 is 17.5% per management's own slide [5].

The quarterly trend is what a high-quality services franchise should look like: 20 consecutive quarters of sequential growth, no air-pocket, with the slope steepening through FY26. The Q4 FY26 sequential growth was a deliberately softer 0.6% in USD terms — CEO Kapil Jain called out the deceleration on the prior call, and ascribed it to a couple of BFSI consulting engagements winding down rather than a demand reset [6]. Management guidance for FY27 is unchanged: top-quartile growth versus the BPM peer group, EBITDA margin held in a 24–28% band, with Q1 FY27 sequentially better than Q4 FY26 [7].

Margins — structural, not cyclical

This is the single most important picture on the page. Three observations:

1. The "old normal" is a 28–31% EBITDA margin (FY21–FY24). FY25 compressed to 25.9% under wage inflation, ramp-up costs for two new delivery sites in Lima (Peru) and Cairo (Egypt), and continued investment in leadership and delivery capability [8].
2. FY26 began the recovery (+132 bps including other income, +117 bps on operating EBITDA per management) [9]. Operating EBITDA margin of 25.6% sits comfortably inside the guided 24–28% band but well below the FY22 peak.
3. The post-FY24 margin compression is not a quality break. Net margin of 17.2% in FY26 is below the 19% peak but materially above the FY19–FY20 baseline; what changed is the mix (more analytics & automation seats, fewer pure transaction-processing seats) and a wage cycle, not the structural economics.

The 24–28% band is therefore an honest range, not a sandbagged number. A reader should expect margin to expand 50–100 bps a year toward the upper bound if revenue mix continues to tilt toward platform-led work, and contract if BFSI wage pressure resurges.

Earnings quality — cash beats earnings

The cleanest test of accounting quality is whether reported profit becomes cash. eClerx's record is unusually clean for an Indian mid-cap.

OCF has exceeded net income every year shown. FY26 set a record: operating cash flow of $97 million and free cash flow of $84 million, 33% and 41% above prior year, with an OCF-to-EBITDA ratio of 75% — "the highest in the last 5 years," per the CFO [10]. FCF/PAT in FY26 was 1.07x — every dollar of accounting profit returned more than a dollar of cash.

Two structural reasons this is reliably true here:

• Depreciation on right-of-use lease assets (Ind-AS 116) reduces P&L but does not consume operating cash — it is recycled below the line as a lease payment in financing activities. So OCF runs structurally above PAT.
• Capex is modest and falling as a share of revenue (2.9% in FY26, $13.3M against $458M revenue; FY25 was 3.6%). This is a people-and-IP business, not a property-and-equipment one — that is why goodwill ($50M) is larger than net property, plant and equipment ($22.6M) [4].

The single line a forensic reader watches: receivables growth versus revenue. In FY26 billed receivables grew to $74.2M from $57.9M (+34.5%), faster than the 22% revenue line — a yellow flag, although the CFO reports DSO at 81 days, broadly in line with prior periods [10]. Worth monitoring; not yet a problem.

Balance sheet — a cash fortress with one ROU caveat

The bar on the right is invisible because there is, effectively, no funded debt. As of 31 March 2026, the balance sheet carries $78 million of cash and equivalents, $33 million of current investments (mutual funds and government securities), and another $5 million of other bank balances — a treasury position of roughly $116 million against zero long-term borrowings [4]. Management treasury policy explicitly limits investments to "highly rated debt oriented mutual funds" [11].

The lease caveat. Lease liabilities for office space sit at $36 million long-term and a similar order short-term — these are real, contractual obligations under Ind-AS 116, but they roll with the business and do not behave like financial debt. The finance cost line ($4.7M in FY26) is almost entirely interest on those ROU liabilities, not on loans [12]. EV/EBITDA reconciliations should treat them as opex-equivalent, not as debt.

Liquidity is, accordingly, abundant. The audited FY25 current ratio was 4.56x [13]; the FY26 print is 3.40x — lower only because current liabilities rose alongside accrued staff bonuses and Q4 buyback dues, not because liquid assets fell.

Returns on capital — a 25–28% ROE franchise

ROE has averaged ~23% over the eight years and ticked up to 27.6% in FY26 — a level only a handful of Indian IT services franchises sustain. Two mechanical reasons it is this high and stays this high:

1. No leverage. ROE = ROA × (Assets/Equity). With near-zero debt and a 1.4x asset-turnover ratio, eClerx earns its ROE on operating quality, not financial gearing.
2. Buybacks. Two consecutive buybacks (FY25 settled July 22, 2024; FY26 settled January 2, 2026) shrank the equity base before the FY26 bonus issue doubled the share count — net of bonus, share count is still down vs three years ago [14] [15].

The FY24-25 dip is the same story as the margin dip: post-leadership-transition investment depressed return on the larger equity base temporarily. FY26 returns it to the FY22-23 zone, and is what underwrites the multiple.

Capital allocation — pay shareholders or sit on it

eClerx returns most of its free cash flow to shareholders, but the form matters: the company keeps the dividend symbolic (Re. 1/share, roughly $0.01, ~1% of EPS) and uses tender-offer buybacks at premium prices as the primary return vehicle. This is the right setup for an Indian tax regime that penalises dividend recipients and rewards buyback participants.

• FY25 buyback: 1,375,000 shares at ₹2,800 per share (about $33), total roughly $45 million, settlement date July 22, 2024 [14].
• FY26 buyback: completed during the year, settlement date January 2, 2026 [15].
• Bonus issue: 1:1 bonus issue effective March 2026, doubling the share count and explaining the apparent FY26 EPS "decline" — purely mechanical [15].
• Dividend: Re. 1 per share (roughly $0.01) recommended for FY26, consistent with the eight-year practice [10].

The Chairman's letter is explicit about the framework: "Our capital allocation discipline remains unchanged — we returned INR 3,900 million to shareholders through buyback & dividend, in line with our long-standing approach of delivering consistent and sustainable value" — about $46 million at the FY25 exchange rate [8]. Read alongside the cash pile, two questions follow: (a) why is the cash position still rising despite the buyback programme — answer: free cash flow is still outpacing returns; (b) is there a logical limit beyond which the company should accelerate returns — yes, and the next buyback announcement is the most plausible catalyst.

Peer positioning — premium economics versus a noisy peer set

The auto-selected peer set spans a mix of Indian BPM listings (FSL, HGS, SAGILITY, ALLDIGI) and US-listed analytics franchises (Genpact, EXLS). Like-for-like comparison is imperfect because the US peers report in USD and are 5–10x eClerx's revenue; the Indian peers vary in margin profile and have meaningfully different business mixes (HGS is undergoing a restructuring with near-zero net margins; FSL is much larger and lower-margin; SAGILITY just IPO'd; ALLDIGI is a small-cap analogue). Take this as a relative-positioning grid, not a buy-vs-sell screen. All revenues converted to USD millions.

What this table says. eClerx prints the second-highest EBITDA margin in the set (behind ALLDIGI, which is roughly 1/7th its revenue) and the second-highest ROE behind ALLDIGI. It is the only peer in this group with zero funded debt and a positive net cash position larger than reported FCF. Genpact and EXLS — the global majors eClerx competes with on analytics mandates in BFSI — have lower net margins (10.9% and 12.0% respectively, FY25) and carry meaningful debt (Genpact has $1.17B of long-term debt against $854M cash). Firstsource, the closest Indian BPM analogue by size, runs half the EBITDA margin and earns ~15% ROE on a leveraged balance sheet.

The honest read: on quality and balance sheet, eClerx is the best franchise in its own peer set. The catch is scale — Genpact's $5.1 billion revenue base buys it negotiating leverage and platform-build budgets eClerx cannot match. The valuation question is whether eClerx's margin premium offsets that scale disadvantage.

Valuation — priced for quality, not for euphoria

At $15.35 (June 18, 2026), eClerx trades at:

• ~19.5x P/E on FY26 diluted EPS of $0.83 (a clean post-bonus number).
• ~11x EV/EBITDA using a market cap of ~$1,412M minus ~$74M of net cash, on FY26 EBITDA of $128M.
• ~5.7% FCF yield to the equity market cap on FY26 FCF of $84M.

For reference, the FY25 Annual Report shows the company trading at 3.91x trailing market-cap-to-revenue and a P/E of 24.2x on FY25 numbers [13] — a year ago, the multiple was richer because FY25 had been a margin trough. The FY26 rerating is partly mechanical (the bonus issue normalised the apparent multiple) and partly fundamental (the 132 bps margin expansion proved the trough was behind).

Where it sits versus the peer set. Genpact trades roughly in line at high-teens P/E on $552M of net income; EXLS at low-twenties P/E given higher ROE; Sagility traded above 30x P/E post-IPO. eClerx is therefore neither cheap nor stretched; the multiple is consistent with a mid-cap, mid-teens-grower with a fortress balance sheet and a 25–28% ROE — exactly what the financials describe. If you believe FY27 operating EBITDA can recover to the FY22–23 zone (28%+) on a $530M revenue base, that is a 14–15x EV/EBITDA story on next-12-months numbers, comfortably within Indian quality-IT-services norms.

The multiple does not price in:

• A second consecutive year of organic high-teens revenue growth in USD.
• A successful conversion of the recently-won large-scale Agentic AI deal into a multi-year run-rate.
• A third buyback at a similar pace if the cash pile keeps rising.

It does price in continued top-quartile-among-peers growth, a 24–28% EBITDA band, and stable BFSI revenue (still 40.8% of the book) [3].

The financial verdict, and the first metric to watch

The financials confirm a high-quality, capital-light, cash-rich Indian BPM franchise rerating off a clean FY26: margins recovered ~130 bps, FCF stepped up 41% to a record, the balance sheet remains debt-free with a ~$116 million treasury, and shareholders have collected ~$46 million a year of buyback-led returns for two consecutive years. They contradict the lazy "Indian small-cap = risky" framing — there is no leverage, no goodwill bloat, no aggressive accounting, and the auditor (Price Waterhouse) issues an unmodified opinion year after year [16].

What is not settled is whether the FY26 OPG EBITDA margin expansion (+117 bps to 25.6%) is the start of a structural climb back toward the FY22 high or the easy part of a one-year normalisation.

The first financial metric to watch is operating EBITDA margin — the new non-other-income metric management started disclosing this year. Another +100–150 bps print in FY27 confirms the rerating; a flatline or compression versus FY26 (i.e. stuck at ~25.6%) would say the margin reset is permanent and the multiple needs to come in. The same metric also captures the single biggest swing factor — AI-led pricing pressure on the transaction-processing book — which will show up here before it shows up anywhere else in the statements.